Literature DB >> 26406866

miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.

Pengda Sun1, Dong Sun2, Xudong Wang1, Tianzhou Liu1, Zhiming Ma1, Liwei Duan3.   

Abstract

microRNAs (miRNAs) are small non-coding RNAs that play important role in a variety of biological processes, and aberrant expression of miRNA is always associated with tumor progression and invasion. However, the role of miR-206 in colorectal cancer (CRC) is still unclear. In this study, the expression of miR-206 in CRC tissue was compared to paired normal adjacent tissue, and results indicate that miRNA-206 levels are significantly lower in CRC tissue compared to control tissue. Kaplan-Meier analysis showed that patients with low miR-206 expression had significantly poorer overall survival. In addition, we found that over-expression of miR-206 can inhibit CRC cell migration and invasion. In conclusion, our results suggest that miR-206 functions as a tumor suppressor by inhibiting CRC migration and invasion. These findings suggest that miR-206 may be useful as a new potential therapeutic target for CRC.

Entities:  

Keywords:  cell growth and invasion; colorectal cancer; miR-206; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26406866     DOI: 10.3233/CBM-150489

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  13 in total

1.  Effect of the miR-96-5p inhibitor and mimic on the migration and invasion of the SW480-7 colorectal cancer cell line.

Authors:  Pei Yuan He; Wai Kien Yip; Mohd Faisal Jabar; Norhafizah Mohtarrudin; Noraini Mohd Dusa; Heng Fong Seow
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

2.  miR-206 inhibits renal cell cancer growth by targeting GAK.

Authors:  Chao Wei; Shen Wang; Zhang-Qun Ye; Zhi-Qiang Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

3.  Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review.

Authors:  Igor Lopes Dos Santos; Karlla Greick Batista Dias Penna; Megmar Aparecida Dos Santos Carneiro; Larisse Silva Dalla Libera; Jéssica Enocencio Porto Ramos; Vera Aparecida Saddi
Journal:  Mol Biol Rep       Date:  2021-02-17       Impact factor: 2.316

4.  Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.

Authors:  Xi Chen; Qing-Qing Tan; Xin-Rui Tan; Shi-Jun Li; Xing-Xing Zhang
Journal:  Cell Death Dis       Date:  2021-08-26       Impact factor: 8.469

Review 5.  miRNA Clusters with Down-Regulated Expression in Human Colorectal Cancer and Their Regulation.

Authors:  Paulína Pidíkova; Richard Reis; Iveta Herichova
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

6.  MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.

Authors:  Young Ran Park; Seung Young Seo; Se Lim Kim; Shi Mao Zhu; Sungkun Chun; Jung-Mi Oh; Min Ro Lee; Seong Hun Kim; In Hee Kim; Seung Ok Lee; Soo Teik Lee; Sang Wook Kim
Journal:  Biosci Rep       Date:  2018-09-19       Impact factor: 3.840

7.  Prognostic value of microRNAs in colorectal cancer: a meta-analysis.

Authors:  Song Gao; Zhi-Ying Zhao; Rong Wu; Yue Zhang; Zhen-Yong Zhang
Journal:  Cancer Manag Res       Date:  2018-04-30       Impact factor: 3.989

8.  MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C.

Authors:  Ming Liao; Lijun Peng
Journal:  Cell Mol Biol Lett       Date:  2020-03-17       Impact factor: 5.787

Review 9.  Angioregulatory microRNAs in Colorectal Cancer.

Authors:  Mohammad Hasan Soheilifar; Michael Grusch; Hoda Keshmiri Neghab; Razieh Amini; Hamid Maadi; Massoud Saidijam; Zhixiang Wang
Journal:  Cancers (Basel)       Date:  2019-12-26       Impact factor: 6.639

10.  PathME: pathway based multi-modal sparse autoencoders for clustering of patient-level multi-omics data.

Authors:  Amina Lemsara; Salima Ouadfel; Holger Fröhlich
Journal:  BMC Bioinformatics       Date:  2020-04-16       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.